ProMIS Neurosciences Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +429.2% | +220.3% | +9.1% | -13.4% | +37.5% | -64.2% | -34.9% | -70.1% | -62.8% | -9.8% | +6.9% | -7.7% | +74.8% | +83.7% | +195.4% | -67.6% | +40.4% | -100.0% | – | |
| – | – | – | – | +11.8% | -44.9% | -63.2% | -63.7% | +635.3% | -22.8% | +5.9% | +29.8% | +42.9% | -18.0% | -36.0% | +24.4% | +27.1% | -58.6% | +204.1% | +3.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -39.8% | -36.0% | +240.4% | -427.9% | – | – | – | |
| – | +2,038.1% | -144.0% | – | – | – | -115.2% | – | – | – | – | -187.8% | – | +153.5% | -4.5% | -302.1% | – | -59.4% | -498.3% | – | |
| – | +125.0% | +171.8% | -81.8% | -87.3% | +91.1% | -78.6% | -73.1% | +59.6% | -100.0% | – | -100.0% | – | +1,993,771.6% | +0.0% | -94.4% | -56.5% | -100.0% | – | – | |
| – | – | +0.0% | -100.2% | – | -85.9% | -82.4% | +0.0% | -102.2% | +1,378.7% | -99.5% | +7.2% | -7.4% | +37.7% | +53,686.5% | – | -102.8% | -49.3% | -48.6% | +1.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | -85.2% | -73.7% | +1,590.1% | -86.7% | +35.6% | +69.3% | +54.1% | -26.6% | +42.3% | -2.5% | +203.3% | +29.2% | -21.8% | -28.5% | +568.5% | -66.0% | +103.4% | +57.1% | -24.9% | |
| – | +0.0% | -197.3% | – | – | – | – | – | – | +2,547.5% | -122.5% | – | -33.9% | -241.7% | – | – | -192.0% | – | -89.7% | -1,135.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.